Summary: Researchers have identified a new body-to-mind mechanism connecting chronic stress and depression. They found that chronic stress raises levels of the enzyme matrix metalloproteinase-8 (MMP-8) in the blood, which can cross into the brain and alter neuronal function. In animal models, this process produced social withdrawal behaviors that mirror a core symptom of depression.
The discovery of MMP-8’s role suggests a promising target for novel depression therapies that intervene at the interface between the immune system and the brain. The findings also underscore the importance of immune–brain interactions in psychiatric disorders and pave the way for clinical research on integrative mind–body treatments.
Key Facts:
- Chronic stress elevates MMP-8 in the bloodstream. This enzyme can infiltrate the brain, alter the extracellular matrix around neurons, and impair neuronal function, contributing to depressive-like behaviors.
- Mice lacking the MMP-8 gene were protected from stress-induced social avoidance, supporting a causal role for MMP-8. Blood samples from people with depression also showed increased monocytes and higher MMP-8 levels relative to healthy individuals.
- Planned clinical studies will test whether modulating brain activity can alter peripheral immune behavior and whether such immune changes influence depressive symptoms, reflecting a holistic treatment strategy.
Source: University of Zurich
Chronic stress produces measurable effects across body systems, including the immune system, and is linked to psychiatric conditions such as major depressive disorder.
Despite mounting evidence connecting peripheral immune alterations to mood disorders, the precise mechanisms by which immune changes affect brain function have remained unclear.
Immune-derived enzyme in the blood alters brain neurons
An international team led by the University of Zurich, together with the University Hospital of Psychiatry Zurich (PUK) and the Icahn School of Medicine at Mount Sinai, uncovered a previously unrecognized pathway. They demonstrated that chronic stress raises levels of matrix metalloproteinase-8 (MMP-8), an enzyme produced by certain myeloid immune cells, in the blood of mice. Comparable elevations were also detected in blood samples from patients diagnosed with depression, according to first author Flurin Cathomas.
The team found that circulating MMP-8 can move from the bloodstream into brain tissue, where it changes the structure of the extracellular matrix that supports neurons. These structural changes disrupt neuronal function in regions linked to motivation and social behavior, leading to social withdrawal in the affected animals—behavior that resembles human depressive symptoms.
Implications for new depression therapies
Cathomas highlights two important implications of the work. First, the results reveal a concrete “body-mind mechanism” whereby peripheral immune activity can directly influence the brain, a process that may be relevant to multiple disorders involving both immune and nervous systems. Second, identifying MMP-8 as a key molecule opens the possibility of developing therapies that target this enzyme or its upstream immune drivers to prevent or reverse stress-related behavioral changes.
Changes to the brain’s extracellular matrix
Detailed experiments showed that chronic stress increases the recruitment of monocytes—an immune cell type—into brain vasculature, especially in areas of the nucleus accumbens tied to reward and social interaction. These monocytes express MMP-8. When MMP-8 invades brain tissue, it remodels the extracellular matrix, a net-like scaffold that surrounds and supports neurons.
Disruption of this matrix alters neuronal signaling. In the study, mice with normal MMP-8 expression developed stress-induced social avoidance and detectable changes in nucleus accumbens neurophysiology. In contrast, mice engineered without the MMP-8 gene did not show these stress-related behavioral or neurophysiological changes, indicating a direct role for MMP-8 in mediating susceptibility to stress.
Blood analyses from human participants reinforced the translational relevance of the findings: people with depression displayed higher numbers of circulating monocytes and increased MMP-8 levels compared with healthy controls.
Toward clinical validation
While additional research is necessary before these discoveries can be translated into routine clinical practice, the study strengthens the view that immune–brain interactions contribute to psychiatric illness. On the PUK’s integrative care ward led by Cathomas, clinicians already apply holistic, evidence-based mind–body approaches informed by such research.
The research team is organizing clinical studies to test whether targeted stimulation of specific brain regions can modulate peripheral immune responses and whether such immune modulation alters depressive symptoms. These trials aim to determine whether altering neural activity can shift immune cell behavior in ways that improve mood and social functioning.
About this psychology research news
Author: Melanie Nyfeler
Source: University of Zurich
Contact: Melanie Nyfeler – University of Zurich
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Peripheral immune-derived matrix metalloproteinase promotes stress susceptibility and depression” by Flurin Cathomas et al. Nature
Abstract
Peripheral immune-derived matrix metalloproteinase promotes stress susceptibility and depression
Psychosocial stress generates wide-ranging effects across physiological systems, including immune and neural circuits. While many preclinical and clinical studies have linked peripheral immune alterations to stress-related conditions such as major depressive disorder (MDD), the mechanisms connecting peripheral immune signals to central nervous system dysfunction have been incompletely understood.
This study reports increased serum expression of the myeloid cell-specific proteinase matrix metalloproteinase-8 (MMP8) in humans with MDD and in stress-susceptible mice exposed to chronic social defeat stress (CSDS). In mice, elevated MMP8 was associated with changes in the ultrastructure of the extracellular space, altered neurophysiology in the nucleus accumbens (NAc), and reduced social behavior.
Using mass cytometry and single-cell RNA sequencing, the authors performed in-depth immune profiling of circulating and brain-infiltrating cells, revealing pronounced stress effects on peripheral monocytes. Both circulating monocytes and monocytes that trafficked into the brain exhibited increased Mmp8 expression following CSDS. Circulating MMP8 was shown to infiltrate the NAc parenchyma and to regulate the extracellular space morphology.
Experimental depletion of MMP8 prevented stress-induced social avoidance and normalized NAc neurophysiology and extracellular structure. Together, these results outline a mechanism by which peripheral immune factors influence central function and behavior under chronic stress. Targeting peripheral immune cell-derived matrix metalloproteinases therefore represents a potential therapeutic strategy for stress-related neuropsychiatric disorders.